Cizzle Biotechnology Holdings Plc (LON:CIZ)
London · Delayed Price · Currency is GBP · Price in GBX 1.100
-0.300 (-21.43%)
Oct 15, 2026, 3:52 PM GMT
LON:CIZ Market Cap
LON:CIZ has a market cap or net worth of 4.67 million as of October 15, 2026. It is the 42,878th most valuable company in the world and the 964th biggest in the United Kingdom. Its market cap has decreased by 15.77% in one year.
Market Cap
4.67M
Enterprise Value
4.59M
Revenue
n/a
Global Rank
Country Rank
#964 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since May 14, 2021, LON:CIZ's market cap has decreased from 23.76M to 4.67M, a decrease of -80.33%. That is a compound annual growth rate of -25.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 4.67M | -23.92% |
| Dec 31, 2025 | 6.14M | - |
| Dec 31, 2024 | 6.14M | -13.40% |
| Dec 29, 2023 | 7.09M | 40.94% |
| Dec 30, 2022 | 5.03M | -33.79% |
| Dec 31, 2021 | 7.60M | -68.00% |
| May 14, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Palatin Technologies | 12.22M |
| Fusion Antibodies | 12.20M |
| Aptamer Group | 11.23M |
| Thalia Therapeutics | 11.10M |
| Genflow Biosciences | 10.20M |
| Solvonis Therapeutics | 7.83M |
| CRISM Therapeutics | 6.93M |
| OptiBiotix Health | 5.84M |